{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:43:44Z","timestamp":1793069024098,"version":"4.5.0"},"reference-count":358,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Cell therapy practices date back to the 19\n                    <jats:sup>th<\/jats:sup>\n                    century and continue to expand on investigational and investment grounds. Cell therapy includes stem cell- and non\u2013stem cell-based, unicellular and multicellular therapies, with different immunophenotypic profiles, isolation techniques, mechanisms of action, and regulatory levels. Following the steps of their predecessor cell therapies that have become established or commercialized, investigational and premarket approval-exempt cell therapies continue to provide patients with promising therapeutic benefits in different disease areas. In this review article, we delineate the vast types of cell therapy, including stem cell-based and non\u2013stem cell-based cell therapies, and create the first-in-literature compilation of the different \u201cmulticellular\u201d therapies used in clinical settings. Besides providing the nuts and bolts of FDA policies regulating their use, we discuss the benefits of cell therapies reported in 3 therapeutic areas\u2014regenerative medicine, immune diseases, and cancer. Finally, we contemplate the recent attention shift toward combined therapy approaches, highlighting the factors that render multicellular therapies a more attractive option than their unicellular counterparts.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2021.756029","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:56:26Z","timestamp":1637542586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":229,"title":["Cell Therapy: Types, Regulation, and Clinical Benefits"],"prefix":"10.3389","volume":"8","author":[{"given":"Abed El-Hakim","family":"El-Kadiry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutih","family":"Rafei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riam","family":"Shammaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5125\/jkaoms.2013.39.5.201","article-title":"A brief overview of cell therapy and its product","volume":"39","author":"Kim","year":"2013","journal-title":"J Korean Assoc Oral Maxillofac Surg."},{"key":"B2","unstructured":"Gene & Cell Therapy FAQs.2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ando.2010.01.003","article-title":"La th\u00e9rapeutique du docteur Brown-S\u00e9quard","volume":"71","author":"Lefr\u00e8re","year":"2010","journal-title":"Ann Endocrinol."},{"key":"B4","unstructured":"San Francisco, CACell Therapy Market Size Analysis Report2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20150017","DOI":"10.1098\/rstb.2015.0017","article-title":"Cell-based therapy technology classifications and translational challenges","volume":"370","author":"Mount","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12015-018-9866-1","article-title":"Biological products: cellular therapy and FDA approved products","volume":"15","author":"Golchin","year":"2019","journal-title":"Stem Cell Rev Reports."},{"key":"B7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00795-017-0173-8","article-title":"The role of nanomaterials in cell delivery systems","volume":"51","author":"Golchin","year":"2018","journal-title":"Med Mol Morphol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41536-021-00133-3","article-title":"Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast","volume":"6","author":"De Pieri","year":"2021","journal-title":"NPJ Regen Med."},{"key":"B10","unstructured":"St. Louis, MOALLOCORD (HPC Cord Blood) Prescribing Information2013"},{"key":"B11","unstructured":"Cleveland, OHCLEVECORD (HPC, Cord Blood) Prescribing Information2016"},{"key":"B12","unstructured":"Long Island City, NYHEMACORD (HPC, Cord Blood) Prescribing Information2011"},{"key":"B13","unstructured":"Durham, NCDUCORD (HPC, Cord Blood) Prescribing Information2012"},{"key":"B14","unstructured":"Aurora, COHPC, Cord Blood Prescribing Information2012"},{"key":"B15","unstructured":"Houston, TXHPC, Cord Blood Prescribing Information2018"},{"key":"B16","unstructured":"Gainesville, FLHPC, Cord Blood Prescribing Information2013"},{"key":"B17","unstructured":"Seattle, WAHPC, Cord Blood Prescribing Information2016"},{"key":"B18","unstructured":"Bothell, WABREYANZI2021"},{"key":"B19","unstructured":"East Hanover, NJKYMRIAH2017"},{"key":"B20","unstructured":"Santa Monica, CAYESCARTA2017"},{"key":"B21","unstructured":"Santa Monica, CATECARTUS2020"},{"key":"B22","unstructured":"Summit, NJABECMA2021"},{"key":"B23","unstructured":"Seattle, WAPROVENGE2010"},{"key":"B24","unstructured":"Canton, MAGINTUIT (Allogeneic Cultured Keratinocytes Fibroblasts in Bovine Collagen) Prescribing Information2012"},{"key":"B25","unstructured":"Exton, PALAVIV2011"},{"key":"B26","unstructured":"Cambridge, MAMACI2016"},{"key":"B27","unstructured":"FDA.Approved Cellular Gene Therapy Products2021"},{"key":"B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cell.2008.01.015","article-title":"Stem Cells, the molecular circuitry of pluripotency and nuclear reprogramming","volume":"132","author":"Jaenisch","year":"2008","journal-title":"Cell."},{"key":"B29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fcell.2016.00134","article-title":"Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics","volume":"4","author":"Singh","year":"2016","journal-title":"Front Cell Dev Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1126\/science.282.5396.2095","article-title":"Eight calves cloned from somatic cells of a single adult","volume":"282","author":"Kato","year":"1998","journal-title":"Science."},{"key":"B32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell."},{"key":"B33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cell.2010.10.008","article-title":"Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues","volume":"143","author":"Hanna","year":"2010","journal-title":"Cell."},{"key":"B34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nmeth.1580","article-title":"A bioinformatic assay for pluripotency in human cells","volume":"8","author":"M\u00fcller","year":"2011","journal-title":"Nat Methods."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1182\/blood-2003-09-3314","article-title":"Gene expression in human embryonic stem cell lines: unique molecular signature","volume":"103","author":"Bhattacharya","year":"2004","journal-title":"Blood."},{"key":"B36","doi-asserted-by":"publisher","first-page":"13350","DOI":"10.1073\/pnas.2235735100","article-title":"Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors","volume":"100","author":"Sperger","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature07213","article-title":"Regulatory networks define phenotypic classes of human stem cell lines","volume":"455","author":"M\u00fcller","year":"2008","journal-title":"Nature."},{"key":"B38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2164-6-99","article-title":"Comparing independent microarray studies: the case of human embryonic stem cells","volume":"6","author":"Su\u00e1rez-Fari\u00f1as","year":"2005","journal-title":"BMC Genomics."},{"key":"B39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/gb-2012-13-10-251","article-title":"The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation","volume":"13","author":"Schmidt","year":"2012","journal-title":"Genome Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cell.2008.02.039","article-title":"An extended transcriptional network for pluripotency of embryonic stem cells","volume":"132","author":"Kim","year":"2008","journal-title":"Cell."},{"key":"B41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.stem.2007.08.003","article-title":"Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells","volume":"1","author":"Pan","year":"2007","journal-title":"Cell Stem Cell."},{"key":"B42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2009.05.015","article-title":"Naive and primed pluripotent states","volume":"4","author":"Nichols","year":"2009","journal-title":"Cell Stem Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/dbio.2001.0501","article-title":"Dynamic reprogramming of DNA methylation in the early mouse embryo","volume":"241","author":"Santos","year":"2002","journal-title":"Dev Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nature07107","article-title":"Genome-scale DNA methylation maps of pluripotent and differentiated cells","volume":"454","author":"Meissner","year":"2008","journal-title":"Nature."},{"key":"B45","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature06968","article-title":"The ground state of embryonic stem cell self-renewal","volume":"453","author":"Ying","year":"2008","journal-title":"Nature."},{"key":"B46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-61779-201-4_17","article-title":"The teratoma assay: an in vivo assessment of pluripotency","volume":"767","author":"Wesselschmidt","year":"2011","journal-title":"Methods Mol Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/0955-0674(95)80071-9","article-title":"In vitro differentiation of embryonic stem cells","volume":"7","author":"Keller","year":"1995","journal-title":"Curr Opin Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1126\/science.1059399","article-title":"Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer","volume":"292","author":"Wakayama","year":"2001","journal-title":"Science (80-)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/cells9030563","article-title":"Recent Progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications","volume":"9","author":"Chu","year":"2020","journal-title":"Cells."},{"key":"B50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/292154a0","article-title":"Establishment in culture of pluripotential cells from mouse embryos","volume":"292","author":"Evans","year":"1981","journal-title":"Nature."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science."},{"key":"B52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0735-7","article-title":"The limited application of stem cells in medicine: a review","volume":"9","author":"Poulos","year":"2018","journal-title":"Stem Cell Res Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/eurheartj\/ehz787","article-title":"A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair","volume":"41","author":"Wysoczynski","year":"2020","journal-title":"Eur Heart J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasch\u00e9","year":"2015","journal-title":"Eur Heart J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4252\/wjsc.v11.i7.421","article-title":"Induced pluripotent stem cells, a giant leap for mankind therapeutic applications","volume":"11","author":"Bragan\u00e7a","year":"2019","journal-title":"World J Stem Cells."},{"key":"B58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/5584_2018_173","article-title":"Clinical applications of induced pluripotent stem cells \u2013 stato attuale","volume":"1079","author":"Kavyasudha","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell\u2013derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/kisup.2011.15","article-title":"Biology of stem cells: an overview","volume":"1","author":"Chagastelles","year":"2011","journal-title":"Kidney Int Suppl."},{"key":"B61","unstructured":"Bethesda, MDThe Adult Stem Cell2016"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2018.07.009","article-title":"Adult stem cells for regenerative therapy","volume":"160","author":"Gurusamy","year":"2018","journal-title":"Prog Mol Biol Transl Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.transci.2014.10.016","article-title":"Hematopoietic stem cells: an overview","volume":"51","author":"Mosaad","year":"2014","journal-title":"Transfus Apher Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.exger.2008.09.001","article-title":"Human skin stem cells and the ageing process","volume":"43","author":"Zouboulis","year":"2008","journal-title":"Exp Gerontol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clineuro.2018.07.013","article-title":"Neural stem cell therapy\u2014brief review","volume":"173","author":"Grochowski","year":"2018","journal-title":"Clin Neurol Neurosurg."},{"key":"B66","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcell.2020.00072","article-title":"Mesenchymal stem cells beyond regenerative medicine","volume":"8","author":"Shammaa","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","article-title":"Mesenchymal stem cells: a new trend for cell therapy","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol Sin."},{"key":"B68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy."},{"key":"B69","unstructured":"ClinicalTrialsGov.Recruiting, Active, not recruiting Studies MSC2021"},{"key":"B70","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"Phase I clinical trial of the treatment of crohn's fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garc\u00eda-Olmo","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"B72","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10517-005-0232-3","article-title":"First experience in the use of bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns","volume":"139","author":"Rasulov","year":"2005","journal-title":"Bull Exp Biol Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5237063","DOI":"10.1155\/2017\/5237063","article-title":"Adipose-derived stromal cells for treatment of patients with chronic ischemic heart disease (mystromalcell trial): a randomized placebo-controlled study","volume":"2017","author":"Qayyum","year":"2017","journal-title":"Stem Cells Int."},{"key":"B74","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-016-0918-5","article-title":"Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy","volume":"14","author":"Comella","year":"2016","journal-title":"J Transl Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/sci-2020-001","article-title":"Current state of stem cell-based therapies: an overview","volume":"7","author":"Aly","year":"2020","journal-title":"Stem Cell Investig."},{"key":"B76","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/ard.2003.011205","article-title":"Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR registry","volume":"63","author":"Farge","year":"2004","journal-title":"Ann Rheum Dis."},{"key":"B77","unstructured":"Renaissance in Immunotherapy in South Korea.2017"},{"key":"B78","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/1744666X.2016.1208086","article-title":"Remestemcel-L for the treatment of graft versus host disease","volume":"13","author":"Locatelli","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B79","unstructured":"ALS (NeuroNata-R2015"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for Complex Perianal fistulas in patients with Crohn's disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu Rev Pathol Mech Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11882-021-00996-y","article-title":"Stem cell therapy as a treatment for autoimmune disease\u2014updates in lupus, scleroderma, and multiple sclerosis","volume":"21","author":"Ramalingam","year":"2021","journal-title":"Curr Allergy Asthma Rep."},{"key":"B84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1191\/0961203304lu491oa","article-title":"High-dose immunosuppression with autologous stem cell transplantation in severe refractory systemic lupus erythematosus","volume":"13","author":"Lisukov","year":"2004","journal-title":"Lupus."},{"key":"B85","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.295.5.527","article-title":"Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus","volume":"295","author":"Burt","year":"2006","journal-title":"J Am Med Assoc."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1378\/chest.127.5.1680","article-title":"Prevalence and reversibility of pulmonary dysfunction in refractory systemic lupus: improvement correlates with disease remission following hematopoietic stem cell transplantation","volume":"127","author":"Traynor","year":"2005","journal-title":"Chest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5500\/wjt.v6.i1.199","article-title":"Hematopoietic stem cell transplantation for auto immune rheumatic diseases","volume":"6","author":"Ramaswamy","year":"2016","journal-title":"World J Transplant."},{"key":"B88","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4252\/wjsc.v11.i4.212","article-title":"Issues and opportunities of stem cell therapy in autoimmune diseases","volume":"11","author":"Muzes","year":"2019","journal-title":"World J Stem Cells."},{"key":"B89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"H\u00fcgle","year":"2010","journal-title":"Haematologica."},{"key":"B90","unstructured":"Alofisel.2018"},{"key":"B91","doi-asserted-by":"publisher","first-page":"127ps9","DOI":"10.1126\/scitranslmed.3003920","article-title":"Pluripotent stem cell-based cancer therapy: promise and challenges","volume":"4","author":"Sharkis","year":"2012","journal-title":"Sci Transl Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-04-0602","article-title":"Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma","volume":"10","author":"Di Nicola","year":"2004","journal-title":"Clin Cancer Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(sici)1097-0215(20000501)86:3<385::aid-ijc13>3.0.co;2-t","article-title":"Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34+ hematopoietic progenitor cells","volume":"86","author":"Mackensen","year":"2000","journal-title":"J Cancer."},{"key":"B94","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12885-015-1241-x","article-title":"Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I\/II clinical trial","volume":"15","author":"Niess","year":"2015","journal-title":"BMC Cancer."},{"key":"B95","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/sctm.18-0230","article-title":"A phase I study to assess the safety and cancer-homing ability of allogeneic bone marrow-derived mesenchymal stem cells in men with localized prostate cancer","volume":"8","author":"Schweizer","year":"2019","journal-title":"Stem Cells Transl Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ymthe.2020.01.019","article-title":"First-in-human, first-in-child trial of autologous MSCs carrying the oncolytic virus icovir-5 in patients with advanced tumors","volume":"28","author":"Ruano","year":"2020","journal-title":"Mol Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"75756","DOI":"10.18632\/oncotarget.20798","article-title":"Stem cells in cancer therapy: opportunities and challenges","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget."},{"key":"B98","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.3390\/ijms22147667","article-title":"The use of stem cell-derived organoids in disease modeling: an update","volume":"22","author":"Azar","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.stem.2015.09.004","article-title":"Regeneration of thyroid function by transplantation of differentiated pluripotent stem cells","volume":"17","author":"Kurmann","year":"2015","journal-title":"Cell Stem Cell."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00249-021-01551-3","article-title":"The role of physical cues in the development of stem cell-derived organoids","volume":"1","author":"Tortorella","year":"2021","journal-title":"Eur Biophys J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.05098.029","article-title":"In vitro generation of human pluripotent stem cell derived lung organoids","volume":"2015","author":"Dye","year":"2015","journal-title":"Elife."},{"key":"B103","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ncb3510","article-title":"A three-dimensional model of human lung development and disease from pluripotent stem cells","volume":"19","author":"Chen","year":"2017","journal-title":"Nat Cell Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","article-title":"Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis","volume":"526","author":"Takasato","year":"2015","journal-title":"Nature."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9715","article-title":"Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids","volume":"6","author":"Freedman","year":"2015","journal-title":"Nat Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s13277-011-0155-8","article-title":"Cancer stem cells and cancer therapy","volume":"32","author":"Soltanian","year":"2011","journal-title":"Tumor Biol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/imm.12866","article-title":"Cancer stem cells as targets for immunotherapy","volume":"153","author":"Codd","year":"2018","journal-title":"Immunology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/jcp.29044","article-title":"Cancer stem cells: a review from origin to therapeutic implications","volume":"235","author":"Atashzar","year":"2020","journal-title":"J Cell Physiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1634\/theoncologist.2019-0517","article-title":"The clinical impact of cancer stem cells","volume":"25","author":"Lathia","year":"2020","journal-title":"Oncologist."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMra1804280","article-title":"Clinical and therapeutic implications of cancer stem cells","volume":"380","author":"Clarke","year":"2019","journal-title":"N Engl J Med."},{"key":"B111","first-page":"89","article-title":"Cell and tissue therapy in regenerative medicin","volume-title":"Stem Cell Transplantation. Advances in Experimental Medicine and Biology","author":"S\u00e1nchez","year":""},{"key":"B112","doi-asserted-by":"publisher","first-page":"e3079","DOI":"10.7717\/peerj.3079","article-title":"Isolation and characterization of human articular chondrocytes from surgical waste after total knee arthroplasty (TKA)","volume":"2017","author":"Naranda","year":"2017","journal-title":"PeerJ."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e3405","DOI":"10.21769\/BioProtoc.3405","article-title":"Platelet isolation and activation assays","volume":"9","author":"Burzynski","year":"2019","journal-title":"Bio-Protocol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"214727","DOI":"10.1155\/2014\/214727","article-title":"Retrospective comparative study of the effects of dendritic cell vaccine and cytokine-induced killer cell immunotherapy with that of chemotherapy alone and in combination for colorectal cancer","volume":"2014","author":"Niu","year":"2014","journal-title":"Biomed Res Int."},{"key":"B115","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1146\/annurev-cellbio-092910-154008","article-title":"Mechanisms of T cell development and transformation","volume":"27","author":"Koch","year":"2011","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1525-1594.1996.tb04522.x","article-title":"Ex vivo manipulation of cell subsets for cell therapies","volume":"20","author":"Nordon","year":"1996","journal-title":"Artif Organs."},{"key":"B117","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/10430340150218431","article-title":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for human somatic cell therapy and gene therapy","volume":"12","year":"2001","journal-title":"Hum Gene Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-6135.2004.0340.x","article-title":"Hepatocyte transplantation","volume":"4","author":"Fox","year":"2004","journal-title":"Am J Transplant."},{"key":"B119","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: current status and future perspectives","volume":"83","author":"Iansante","year":"2018","journal-title":"Pediatr Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care."},{"key":"B121","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: recent progress and future directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"280ps7","DOI":"10.1126\/scitranslmed.aaa3643","article-title":"Adoptive cellular therapy: a race to the finish line","volume":"7","author":"June","year":"2015","journal-title":"Sci Transl Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"113345","DOI":"10.18632\/oncotarget.23007","article-title":"Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget."},{"key":"B124","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","article-title":"Adoptive cellular therapies: the current landscape","volume":"474","author":"Rohaan","year":"2019","journal-title":"Virchows Arch."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/jnci\/86.15.1159","article-title":"Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J Natl Cancer Inst."},{"key":"B126","doi-asserted-by":"publisher","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B127","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00262-016-1947-x","article-title":"Rejection versus escape: the tumor MHC dilemma","volume":"66","author":"Garrido","year":"2017","journal-title":"Cancer Immunol Immunother."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/jid.2011.160","article-title":"T-cell receptor gene therapy: critical parameters for clinical success","volume":"131","author":"Linnemann","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science."},{"key":"B130","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature."},{"key":"B131","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5114\/wo.2018.73892","article-title":"Versatile CAR T-cells for cancer immunotherapy","volume":"2","author":"Chu","year":"2017","journal-title":"Wspolczesna Onkol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B133","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/0006-291X(87)90502-X","article-title":"Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regions","volume":"149","author":"Kuwana","year":"1987","journal-title":"Biochem Biophys Res Commun."},{"key":"B134","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm827","article-title":"Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15","volume":"9","author":"Brentjens","year":"2003","journal-title":"Nat Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00890-6","article-title":"Gene modification strategies for next-generation CAR T cells against solid cancers","volume":"13","author":"Tian","year":"2020","journal-title":"J Hematol Oncol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.21037\/sci.2018.11.05","article-title":"Current development of chimeric antigen receptor T-cell therapy","volume":"5","author":"Wang","year":"2018","journal-title":"Stem Cell Investig."},{"key":"B137","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-94-017-7555-7_4","article-title":"Adoptive cellular therapy (ACT) for cancer treatment","volume":"909","author":"Yang","year":"2016","journal-title":"Adv Exp Med Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1084\/jem.159.2.495","article-title":"Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2","volume":"159","author":"Mazumder","year":"1984","journal-title":"J Exp Med."},{"key":"B139","unstructured":"Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells16739 Schmidt-WolfI LefterovaP MehtaB FernandezL HuhnD BlumeK 7694868Exp Hematol.211993"},{"key":"B140","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"Chien","year":"2014","journal-title":"Annu Rev Immunol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/2162402X.2014.992749","article-title":"Ex vivo expanded human circulating v\u03b41 \u03b3\u03b4T cells exhibit favorable therapeutic potential for colon cancer","volume":"4","author":"Wu","year":"2015","journal-title":"Oncoimmunology."},{"key":"B142","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I Cytotoxic cells with specificity for mouse moloney leukemia cells specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol."},{"key":"B143","unstructured":"High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival updateS114 AtkinsM KunkelL SznolM RosenbergS 10685652Cancer J Sci Am.62000"},{"key":"B144","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","article-title":"Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression","volume":"17","author":"Parkhurst","year":"2011","journal-title":"Clin Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/scrt345","article-title":"Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages","volume":"4","author":"Ledford","year":"2013","journal-title":"Stem Cell Res Ther."},{"key":"B146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13287-015-0007-3","article-title":"Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases","volume":"6","author":"Ledford","year":"2015","journal-title":"Stem Cell Res Ther."},{"key":"B147","unstructured":"How does autologous cell therapy work? Adv Cell Ther.2021"},{"key":"B148","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/scrt117","article-title":"The aastrom experience","volume":"3","author":"Bartel","year":"2012","journal-title":"Stem Cell Res Ther."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1257452","DOI":"10.1080\/2162402X.2016.1257452","article-title":"Tumor-infiltrating lymphocyte composition, organization and PD-1\/PD-l1 expression are linked in breast cancer","volume":"6","author":"Buisseret","year":"2017","journal-title":"Oncoimmunology."},{"key":"B150","unstructured":"What is a Stem Cell Or Bone Marrow Transplant?2019"},{"key":"B151","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12891-020-3126-7","article-title":"Injections of concentrated bone marrow aspirate as treatment for discogenic pain: a retrospective analysis","volume":"21","author":"Wolff","year":"2020","journal-title":"BMC Musculoskelet Disord."},{"key":"B152","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.cellimm.2018.01.013","article-title":"Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone?","volume":"343","author":"Badalamenti","year":"2019","journal-title":"Cell Immunol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1158\/0008-5472.CAN-20-3213","article-title":"Tet2 inactivation enhances the antitumor activity of tumor-infiltrating lymphocytes","volume":"81","author":"Lee","year":"2021","journal-title":"Cancer Res."},{"key":"B155","unstructured":"Immune Checkpoint Inhibitors.2019"},{"key":"B156","doi-asserted-by":"publisher","first-page":"84","DOI":"10.7150\/jca.5482","article-title":"Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories","volume":"4","author":"Man","year":"2013","journal-title":"J Cancer."},{"key":"B157","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.4049\/jimmunol.120.6.1876","article-title":"In situ lymphoid cells of mouse mammary tumors","volume":"120","author":"Blazar","year":"1978","journal-title":"J Immunol."},{"key":"B158","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4049\/jimmunol.111.3.836","article-title":"Separation of lymphocytes from disaggregated mouse malignant neoplasms by sedimentation in gradients of ficoll in tissue culture medium","volume":"111","author":"Zettergren","year":"1973","journal-title":"J Immunol."},{"key":"B159","first-page":"1067","article-title":"In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2","volume":"79","author":"Spiess","year":"1987","journal-title":"J Natl Cancer Inst."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1016\/j.molonc.2015.10.018","article-title":"Tumor-infiltrating lymphocytes for the treatment of metastatic cancer","volume":"9","author":"Geukes Foppen","year":"2015","journal-title":"Mol Oncol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1158\/2326-6066.CIR-18-0342","article-title":"Immune cell gene signatures for profiling the microenvironment of solid tumors","volume":"6","author":"Nirmal","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B163","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods."},{"key":"B164","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/PPO.0000000000000162","article-title":"Tumor-infiltrating lymphocyte therapy: addressing prevailing questions","volume":"21","author":"Radvanyi","year":"2015","journal-title":"Cancer J."},{"key":"B165","doi-asserted-by":"publisher","first-page":"593848","DOI":"10.3389\/fonc.2020.593848","article-title":"Synthetic TILs: engineered tumor-infiltrating lymphocytes with improved therapeutic potential","volume":"10","author":"Jim\u00e9nez-Reinoso","year":"2021","journal-title":"Front Oncol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bjc.6690800","article-title":"Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-1 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma","volume":"81","author":"Schmidt-Wolf","year":"1999","journal-title":"Br J Cancer."},{"key":"B167","unstructured":"Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience564559 SeminoC MartiniL QueiroloP CangemiG CostaR AlloisioA 10697634Anticancer Res.191999"},{"key":"B168","unstructured":"Molecular mechanisms of lymphocyte-mediated killing114553 YoungJ LiuC PersechiniP Braz J Med Biol Res.211988"},{"key":"B169","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nmat1421","article-title":"Porous scaffold design for tissue engineering","volume":"4","author":"Hollister","year":"2005","journal-title":"Nat Mater."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1039\/b814285h","article-title":"Modular tissue engineering: engineering biological tissues from the bottom up","volume":"5","author":"Nichol","year":"2009","journal-title":"Soft Matter."},{"key":"B171","unstructured":"Road Canton, MAComplete List of Currently Approved Premarket Applications (PMAs)2021"},{"key":"B172","unstructured":"La Jolla, CADermagraft2001"},{"key":"B173","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1369-7021(04)00234-2","article-title":"Cell sheet engineering","volume":"7","author":"Yamato","year":"2004","journal-title":"Mater Today."},{"key":"B174","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/adma.200701978","article-title":"Tissue engineering based on cell sheet technology","volume":"19","author":"Matsuda","year":"2007","journal-title":"Adv Mater."},{"key":"B175","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nprot.2012.027","article-title":"Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro","volume":"7","author":"Haraguchi","year":"2012","journal-title":"Nat Protoc."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms2406","article-title":"In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels","volume":"4","author":"Sekine","year":"2013","journal-title":"Nat Commun."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep01316","article-title":"In vitro engineering of vascularized tissue surrogates","volume":"3","author":"Sakaguchi","year":"2013","journal-title":"Sci Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.biomaterials.2013.12.014","article-title":"Automatic fabrication of 3-dimensional tissues using cell sheet manipulator technique","volume":"35","author":"Kikuchi","year":"2014","journal-title":"Biomaterials."},{"key":"B179","unstructured":"Cambridge, MAEpicel (Cultured Epidermal Autografts) Directions for Use2016"},{"key":"B180","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/ciia.2007.2.1.93","article-title":"A review of a bi-layered living cell treatment (Apligraf \u00ae) in the treatment of venous leg ulcers and diabetic foot ulcers","volume":"2","author":"Zaulyanov","year":"2007","journal-title":"Clin Interv Aging."},{"key":"B181","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1615\/CritRevBiomedEng.v37.i4-5.50","article-title":"Stem cells for skin tissue engineering and wound healing","volume":"37","author":"Chen","year":"2009","journal-title":"Crit Rev Biomed Eng."},{"key":"B182","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: Implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"B183","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/CIRCRESAHA.107.159475","article-title":"Population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks","volume":"102","author":"Traktuev","year":"2008","journal-title":"Circ Res."},{"key":"B184","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1089\/ten.2006.12.3375","article-title":"Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection","volume":"12","author":"Matsumoto","year":"2006","journal-title":"Tissue Eng."},{"key":"B185","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/asj\/sjy160","article-title":"Adipose-derived stem cells in aesthetic surgery","volume":"39","author":"Glass","year":"2019","journal-title":"Aesthetic Surg J."},{"key":"B186","unstructured":"ClinicalTrialsGovNCT04050111. The Evaluation Of Safety And Effectiveness Of Intraarticular Administration Of Autologous Stromal-Vascular Fraction Of Adipose Tissue Cells For Treatment Of Knee Joint Arthrosis2019"},{"key":"B187","unstructured":"ClinicalTrialsGovNCT04238468. Scar Tissue Analysis After Intraoperative Application Of Stromal Vascular Fraction Cells Into Suture Line2020"},{"key":"B188","unstructured":"ClinicalTrialsGovNCT04771442. Stem Cell Treatment Of Peyronie's Disease2021"},{"key":"B189","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.reth.2020.01.004","article-title":"Advances in regenerative therapy: a review of the literature and future directions","volume":"14","author":"Ntege","year":"2020","journal-title":"Regen Ther."},{"key":"B190","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","article-title":"Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the international federation for adipose therapeutics and science (IFATS) and the international society for cellular therapy (ISCT)","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy."},{"key":"B191","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bjps.2015.10.014","article-title":"Stromal vascular fraction: a regenerative reality? part 2: mechanisms of regenerative action","volume":"69","author":"Guo","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg."},{"key":"B192","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1634\/stemcells.19-2-108","article-title":"Peripheral blood stem cells for allogeneic transplantation: a review","volume":"19","author":"Cutler","year":"2001","journal-title":"Stem Cells."},{"key":"B193","unstructured":"Stem Cell or Bone Marrow Transplant.2020"},{"key":"B194","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/sj.bmt.1702875","article-title":"Peripheral blood stem cell donation: an analysis from the international bone marrow transplant registry (IBMTR) and European group for blood and marrow transplant (EBMT) databases","volume":"27","author":"Anderlini","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"B195","unstructured":"RindyLJ ChambersAR Treasure Island, FLStatPearls PublishingBone Marrow Aspiration Biopsy2021"},{"key":"B196","first-page":"109","article-title":"Bone marrow harvesting for HSCT","volume-title":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies.","author":"Gorin","year":""},{"key":"B197","doi-asserted-by":"publisher","first-page":"20012","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B198","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1051\/sicotj\/2017007","article-title":"systematic review of the concept and clinical applications of bone marrow aspirate concentrate in orthopaedics","volume":"3","author":"Imam","year":"2017","journal-title":"Sicot J."},{"key":"B199","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tmrv.2018.11.003","article-title":"peripheral blood or bone marrow stem Cells? practical considerations in hematopoietic stem cell transplantation","volume":"33","author":"Amouzegar","year":"2019","journal-title":"Transfus Med Rev."},{"key":"B200","doi-asserted-by":"crossref","DOI":"10.1201\/b14000","volume-title":"Hematopoietic Stem Cell Transplantation","author":"Ho","year":"2000"},{"key":"B201","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.bbmt.2018.06.023","article-title":"Differences in cellular composition of peripheral blood stem cell grafts from healthy stem cell donors mobilized with either granulocyte colony-stimulating factor (G-CSF) alone or G-CSF and plerixafor","volume":"24","author":"Teipel","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1702464","article-title":"Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor","volume":"26","author":"Gyger","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"B203","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1182\/blood.V98.10.2900","article-title":"Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?","volume":"98","author":"K\u00f6rbling","year":"2001","journal-title":"Blood."},{"key":"B204","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1634\/stemcells.21-2-143","article-title":"Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation","volume":"21","author":"Yasui","year":"2003","journal-title":"Stem Cells."},{"key":"B205","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbmt.2014.11.675","article-title":"Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from eurocord (Cord blood committee of cellular therapy & immunobiology working party of EBMT) and chronic malignancies working party","volume":"21","author":"Robin","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B206","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/bmt.2012.66","article-title":"The EBMT activity survey: 1990-2010","volume":"47","author":"Passweg","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B207","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B208","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1007\/s11999-014-3548-3","article-title":"Bone marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the Tibia","volume":"472","author":"Lee","year":"2014","journal-title":"Clin Orthop Relat Res."},{"key":"B209","doi-asserted-by":"publisher","first-page":"622573","DOI":"10.3389\/fmed.2021.622573","article-title":"Autologous BMAC therapy improves spinal degenerative joint disease in lower back pain patients","volume":"8","author":"El Kadiry","year":"2021","journal-title":"Front Med."},{"key":"B210","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fbioe.2020.00202","article-title":"Intralesional injection of bone marrow aspirate concentrate for the treatment of osteonecrosis of the knee secondary to systemic lupus erythematosus: a case report","volume":"8","author":"Kouroupis","year":"2020","journal-title":"Front Bioeng Biotechnol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1549826","article-title":"Comparative analysis of cellular and growth factor composition in bone marrow aspirate concentrate and platelet-rich plasma","volume":"2018","author":"Sugaya","year":"2018","journal-title":"Bone Marrow Res."},{"key":"B212","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4081\/or.2016.6659","article-title":"The basic science of bone marrow aspirate concentrate in chondral injuries","volume":"8","author":"Holton","year":"2016","journal-title":"Orthop Rev."},{"key":"B213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325967119893634","article-title":"Evaluation of the consistency and composition of commercially available bone marrow aspirate concentrate systems","volume":"8","author":"Dragoo","year":"2020","journal-title":"Orthop J Sport Med."},{"key":"B214","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jcla.20008","article-title":"Pathologist's perspective on bone marrow aspiration and biopsy: I. performing a bone marrow examination","volume":"18","author":"Riley","year":"2004","journal-title":"J Clin Lab Anal."},{"key":"B215","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1016\/j.eats.2016.10.024","article-title":"Bone marrow aspirate concentrate harvesting and processing technique","volume":"6","author":"Chahla","year":"2017","journal-title":"Arthrosc Tech."},{"key":"B216","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/ijms21093224","article-title":"Bone marrow aspirate concentrate: its uses in osteoarthritis","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B217","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1515\/med-2016-0048","article-title":"Platelet rich plasma: a short overview of certain bioactive components","volume":"11","author":"Pavlovic","year":"2016","journal-title":"Open Med."},{"key":"B218","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0974-2077.150734","article-title":"Principles and methods of preparation of platelet-rich plasma: a review and author\u2032s perspective","volume":"7","author":"Dhurat","year":"2014","journal-title":"J Cutan Aesthet Surg."},{"key":"B219","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.3390\/ijms20174185","article-title":"Role of NF-\u03baB in platelet function","volume":"20","author":"Kojok","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B220","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3390\/ijms22083999","article-title":"The role of the proteasome in platelet function","volume":"22","author":"El-Kadiry","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325967116675272","article-title":"Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits","volume":"5","author":"Fitzpatrick","year":"2017","journal-title":"Orthop J Sport Med."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40729-018-0140-8","article-title":"Spectrophotometric determination of platelet counts in platelet-rich plasma","volume":"4","author":"Kitamura","year":"2018","journal-title":"Int J Implant Dent."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.23812\/20-278-A","article-title":"Cell and platelet composition assays by flow cytometry: basis for new platelet-rich fibrin methodologies","volume":"34","author":"De Oliveira","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B224","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20944\/preprints202010.0069.v1","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/09537104.2012.684730","article-title":"The role of platelet-rich plasma in tissue regeneration","volume":"24","author":"Alsousou","year":"2013","journal-title":"Platelets."},{"key":"B226","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3810\/psm.2011.02.1861","article-title":"Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use","volume":"39","author":"Redler","year":"2011","journal-title":"Phys Sportsmed."},{"key":"B227","unstructured":"Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation Homologous Use - Guidance for Industry and Food and Drug Administration Staff2020"},{"key":"B228","unstructured":"Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions Answers Regarding the Scope of the Exception; Guidance for Industry.2017"},{"key":"B229","unstructured":"INSIGHT: FDA's Aggressive Enforcement Against Stem Cell Companies Starting to Ripen. US Law Week.2019"},{"key":"B230","unstructured":"Statement on stem cell clinic permanent injunction FDA's ongoing efforts to protect patients from risks of unapproved products. FDA Statement.2019"},{"key":"B231","unstructured":"Column: Judge Hands FDA a Loss On Stem Cell Clinics2020"},{"key":"B232","unstructured":"CaliforniaUnited States of America v. California Stem Cell Treatment Center, Inc., et al2020"},{"key":"B233","unstructured":"Canton, MAApligraf2001"},{"key":"B234","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1073\/pnas.1508520112","article-title":"Regenerative medicine: current therapies and future directions","volume":"112","author":"Mao","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B235","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J Health Econ."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1056\/NEJMp1500848","article-title":"The $2.6 billion pill \u2014 methodologic and policy considerations","volume":"372","author":"Avorn","year":"2015","journal-title":"N Engl J Med."},{"key":"B237","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41587-019-0175-2","article-title":"Pre-market development times for biologic versus small-molecule drugs","volume":"37","author":"Beall","year":"2019","journal-title":"Nat Biotechnol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cells10020240","article-title":"The future of regenerative medicine: cell therapy using pluripotent stem cells and acellular therapies based on extracellular vesicles","volume":"10","author":"Jarrige","year":"2021","journal-title":"Cells."},{"key":"B239","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3810\/psm.2014.09.2076","article-title":"The use of platelet-rich plasma for the treatment of osteoarthritis","volume":"42","author":"Jayabalan","year":"2014","journal-title":"Phys Sportsmed."},{"key":"B240","doi-asserted-by":"publisher","first-page":"e000237","DOI":"10.1136\/bmjsem-2017-000237","article-title":"Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: Systematic review and meta-analysis of randomised injection-controlled trials","volume":"3","author":"Miller","year":"2017","journal-title":"BMJ Open Sport Exerc Med."},{"key":"B241","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s12178-018-9527-7","article-title":"Current clinical recommendations for use of platelet-rich plasma","volume":"11","author":"Le","year":"2018","journal-title":"Curr Rev Musculoskelet Med."},{"key":"B242","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1177\/0363546515572777","article-title":"Platelet-rich plasma reduces retear rates after arthroscopic repair of small- and medium-sized rotator cuff tears but is not cost-effective","volume":"43","author":"Vavken","year":"2015","journal-title":"Am J Sports Med."},{"key":"B243","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/0363546515620383","article-title":"Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis","volume":"44","author":"Dallari","year":"2016","journal-title":"Am J Sports Med."},{"key":"B244","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/0363546516665809","article-title":"Hyaluronic acid versus platelet-rich plasma","volume":"45","author":"Cole","year":"2017","journal-title":"Am J Sports Med."},{"key":"B245","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1177\/0363546514541540","article-title":"Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial","volume":"42","author":"A Hamid","year":"2014","journal-title":"Am J Sports Med."},{"key":"B246","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","article-title":"Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma","volume":"39","author":"Sundman","year":"2011","journal-title":"Am J Sports Med."},{"key":"B247","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.reth.2016.01.009","article-title":"Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies","volume":"4","author":"Azuma","year":"2016","journal-title":"Regen Ther."},{"key":"B248","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/14712598.2019.1671970","article-title":"Stromal vascular fraction technologies and clinical applications","volume":"19","author":"Andia","year":"2019","journal-title":"Expert Opin Biol Ther."},{"key":"B249","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/01.prs.0000256047.47909.71","article-title":"Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells","volume":"119","author":"Rigotti","year":"2007","journal-title":"Plast Reconstr Surg."},{"key":"B250","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/genes8100270","article-title":"The effect of intra-articular injection of autologous microfragmented fat tissue on proteoglycan synthesis in patients with knee osteoarthritis","volume":"8","author":"Hudetz","year":"2017","journal-title":"Genes."},{"key":"B251","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.reth.2017.04.002","article-title":"Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee","volume":"6","author":"Yokota","year":"2017","journal-title":"Regen Ther."},{"key":"B252","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15283\/ijsc18101","article-title":"Possibility of injecting adipose-derived stromal vascular fraction cells to accelerate microcirculation in ischemic diabetic feet: a pilot study","volume":"12","author":"Moon","year":"2019","journal-title":"Int J Stem Cells."},{"key":"B253","unstructured":"Recovery of function in anal incontinence after micro-fragmented fat graft (Lipogems\u00ae) injection: two years follow up of the first 5 cases.e1544 GioriA TremoladaC VailatiR NavoneS. MarfiaG CaplanA CellR4.32015"},{"key":"B254","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1097\/GOX.0000000000000621","article-title":"Efficacy of autologous microfat graft on facial handicap in systemic sclerosis patients","volume":"4","author":"Sautereau","year":"2016","journal-title":"Plast Reconstr Surg-Glob Open."},{"key":"B255","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000448180","article-title":"Adipose tissue-derived stem cells in regenerative medicine","volume":"43","author":"Frese","year":"2016","journal-title":"Transfus Med Hemotherapy."},{"key":"B256","unstructured":"ClinicalTrialsGovRecruiting, Active, Not Recruiting Studies ADSC2021"},{"key":"B257","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B258","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/asj\/sjv135","article-title":"Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint","volume":"36","author":"Fodor","year":"2016","journal-title":"Aesthetic Surg J."},{"key":"B259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jgm.3002","article-title":"Intra-articular injection of autologous adipose-derived mesenchymal stem cells in the treatment of knee osteoarthritis","volume":"20","author":"Spasovski","year":"2018","journal-title":"J Gene Med."},{"key":"B260","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.scr.2016.12.001","article-title":"Non-reconstructable peripheral vascular disease of the lower extremity in ten patients treated with adipose-derived stromal vascular fraction cells","volume":"18","author":"Carstens","year":"2017","journal-title":"Stem Cell Res."},{"key":"B261","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3727\/096368914X685636","article-title":"Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis","volume":"24","author":"Papa","year":"2015","journal-title":"Cell Transplant."},{"key":"B262","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial","volume":"74","author":"Granel","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B263","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/codi.13555","article-title":"Novel method for treatment of chronic anal fissure: adipose-derived regenerative cells \u2013 a pilot study","volume":"19","author":"Andjelkov","year":"2017","journal-title":"Color Dis."},{"key":"B264","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3349\/ymj.2016.57.5.1152","article-title":"Adipose-derived regenerative cell injection therapy for postprostatectomy incontinence: a phase i clinical study","volume":"57","author":"Choi","year":"2016","journal-title":"Yonsei Med J."},{"key":"B265","doi-asserted-by":"publisher","first-page":"676","DOI":"10.4252\/wjsc.v12.i7.676","article-title":"Application and prospect of adipose stem cell transplantation in treating lymphedema","volume":"12","author":"Li","year":"2020","journal-title":"World J Stem Cells."},{"key":"B266","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jcyt.2018.12.005","article-title":"In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials","volume":"21","author":"Tappenbeck","year":"2019","journal-title":"Cytotherapy."},{"key":"B267","unstructured":"A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: A clinical case report3639 YamadaY UedaM HibiH BabaS 16939018Int J Periodontics Restorative Dent.262006"},{"key":"B268","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00167-019-05688-9","article-title":"Good mid-term outcomes after adipose-derived culture-expanded mesenchymal stem cells implantation in knee focal cartilage defects","volume":"28","author":"Kyriakidis","year":"2020","journal-title":"Knee Surgery, Sport Traumatol Arthrosc."},{"key":"B269","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcms.2017.11.004","article-title":"Repair of maxillary cystic bone defects with mesenchymal stem cells seeded on a cross-linked serum scaffold","volume":"46","author":"Redondo","year":"2018","journal-title":"J Cranio-Maxillofacial Surg."},{"key":"B270","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.12.010","article-title":"Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial","volume":"92","author":"Lu","year":"2011","journal-title":"Diabetes Res Clin Pract."},{"key":"B271","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2007.11.040","article-title":"Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction","volume":"51","author":"Hahn","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B272","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6","article-title":"Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1\u03b1","volume":"166","author":"Haynesworth","year":"1996","journal-title":"J Cell Physiol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/S0003-4975(02)03952-8","article-title":"Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs","volume":"74","author":"Min","year":"2002","journal-title":"Ann Thorac Surg."},{"key":"B274","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/370621","article-title":"Efficacy of autologous bone marrow concentrate for knee osteoarthritis with and without adipose graft","volume":"2014","author":"Centeno","year":"2014","journal-title":"Biomed Res Int."},{"key":"B275","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/0363546516662455","article-title":"Prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis","volume":"45","author":"Shapiro","year":"2017","journal-title":"Am J Sports Med."},{"key":"B276","unstructured":"ClinicalTrialsGovSearch of: Recruiting, Active, not recruiting Studies BMAC2021"},{"key":"B277","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.avsg.2008.02.017","article-title":"Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation","volume":"22","author":"Weel","year":"2008","journal-title":"Ann Vasc Surg."},{"key":"B278","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2007.02.030","article-title":"The chemokine system in arteriogenesis and hind limb ischemia","volume-title":"J Vasc Surg.","author":"Shireman","year":"2007"},{"key":"B279","unstructured":"Diseases of the Immune System. Genes Dis.1998"},{"key":"B280","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cnur.2018.04.002","article-title":"Immunosuppressive\/autoimmune disorders","volume":"53","author":"Richard-Eaglin","year":"2018","journal-title":"Nurs Clin North Am."},{"key":"B281","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2128","article-title":"Cell therapy for autoimmune diseases","volume":"9","author":"Dazzi","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"B282","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1016\/j.transproceed.2007.08.103","article-title":"Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease","volume":"39","author":"Fang","year":"2007","journal-title":"Transplant Proc."},{"key":"B283","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/stem.1357","article-title":"Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for crohn's fistula","volume":"31","author":"Lee","year":"2013","journal-title":"Stem Cells."},{"key":"B284","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/IMCRJ.S163612","article-title":"First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study","volume":"11","author":"Comella","year":"2018","journal-title":"Int Med Case Rep J."},{"key":"B285","doi-asserted-by":"publisher","first-page":"2416192","DOI":"10.1155\/2016\/2416192","article-title":"Improvement of mouth functional disability in systemic sclerosis patients over one year in a trial of fat transplantation versus adipose-derived stromal cells","volume":"2016","author":"Onesti","year":"2016","journal-title":"Stem Cells Int."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8761485","article-title":"Platelet rich plasma for treatment of rheumatoid arthritis: case series and review of literature","volume":"2020","author":"Badsha","year":"2020","journal-title":"Case Rep Rheumatol."},{"key":"B287","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood."},{"key":"B288","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front Immunol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B290","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical tolerogenic dendritic cells: exploring therapeutic impact on human autoimmune disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front Immunol."},{"key":"B291","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/dc15-0090","article-title":"Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia","volume":"38","author":"Choudhary","year":"2015","journal-title":"Diabetes Care."},{"key":"B292","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1182\/bloodadvances.2020003176","article-title":"Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy","volume":"4","author":"Jhaveri","year":"2020","journal-title":"Blood Adv."},{"key":"B293","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41577-018-0042-2","article-title":"Cells for infection, autoimmunity and allotransplantation","volume":"18","author":"Maldini","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B294","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int J Oncol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00962-7","article-title":"BCMA-targeted immunotherapy for multiple myeloma","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1182\/blood.V99.5.1517","article-title":"Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients","volume":"99","author":"Timmerman","year":"2002","journal-title":"Blood."},{"key":"B297","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1158\/1078-0432.CCR-13-0282","article-title":"Vaccination with dendritic cell\/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients","volume":"19","author":"Rosenblatt","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B298","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2017-04-780155","article-title":"Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia","volume":"130","author":"Anguille","year":"2017","journal-title":"Blood."},{"key":"B299","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/02688697.2014.994473","article-title":"Active dendritic cell immunotherapy for glioblastoma: current status and challenges","volume":"29","author":"Polyzoidis","year":"2015","journal-title":"Br J Neurosurg."},{"key":"B300","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/CJI.0b013e31826f79c8","article-title":"Tumor stem cell antigens as consolidative active specific immunotherapy: A randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanoma","volume":"35","author":"Dillman","year":"2012","journal-title":"J Immunother."},{"key":"B301","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1158\/1078-0432.CCR-15-2205","article-title":"Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells","volume":"22","author":"Schreibelt","year":"2016","journal-title":"Clin Cancer Res."},{"key":"B302","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-12-2583","article-title":"Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients","volume":"73","author":"Tel","year":"2013","journal-title":"Cancer Res."},{"key":"B303","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00262-016-1905-7","article-title":"Phase I\/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma","volume":"65","author":"Akasaki","year":"2016","journal-title":"Cancer Immunol Immunother."},{"key":"B304","doi-asserted-by":"publisher","first-page":"368ra171","DOI":"10.1126\/scitranslmed.aag1298","article-title":"Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions","volume":"8","author":"Rosenblatt","year":"2016","journal-title":"Sci Transl Med."},{"key":"B305","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N Engl J Med."},{"key":"B306","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s12094-020-02344-4","article-title":"Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment","volume":"22","author":"Rodr\u00edguez","year":"2020","journal-title":"Clin Transl Oncol."},{"key":"B307","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1182\/blood-2019-131056","article-title":"A Bcma and CD19 Bispecific CAR-T for relapsed and refractory multiple myeloma","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood."},{"key":"B308","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science."},{"key":"B309","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1182\/blood-2009-03-211714","article-title":"Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood."},{"key":"B310","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","article-title":"A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response","volume":"21","author":"Robbins","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B311","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.2017.35.15_suppl.3000","article-title":"Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1c259t in HLA-A2+ patients with synovial sarcoma (NCT01343043)","volume":"35","author":"Mackall","year":"2017","journal-title":"J Clin Oncol."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma","volume":"319","author":"Rosenberg","year":"1988","journal-title":"N Engl J Med."},{"key":"B313","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med."},{"key":"B315","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jnci\/85.8.622","article-title":"Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer","volume":"85","author":"Rosenberg","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"B316","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00002371-200409000-00009","article-title":"Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma","volume":"27","author":"Dillman","year":"2004","journal-title":"J Immunother."},{"key":"B317","doi-asserted-by":"publisher","first-page":"7125","DOI":"10.4049\/jimmunol.173.12.7125","article-title":"Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy","volume":"173","author":"Robbins","year":"2004","journal-title":"J Immunol."},{"key":"B318","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CJI.0b013e31815a121b","article-title":"Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas","volume":"31","author":"Weng","year":"2008","journal-title":"J Immunother."},{"key":"B319","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.dld.2008.04.007","article-title":"A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma","volume":"41","author":"Hui","year":"2009","journal-title":"Dig Liver Dis."},{"key":"B320","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1053\/j.gastro.2015.02.055","article-title":"Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma","volume":"148","author":"Lee","year":"2015","journal-title":"Gastroenterology."},{"key":"B321","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/intimm\/dxn042","article-title":"Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers","volume":"20","author":"Sangiolo","year":"2008","journal-title":"Int Immunol."},{"key":"B322","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood."},{"key":"B323","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/14653249.2010.515582","article-title":"A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer","volume":"13","author":"Geller","year":"2011","journal-title":"Cytotherapy."},{"key":"B324","doi-asserted-by":"publisher","first-page":"603871","DOI":"10.1155\/2014\/603871","article-title":"Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy","volume":"2014","author":"Zhu","year":"2014","journal-title":"Biomed Res Int."},{"key":"B325","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3892\/ol.2016.4273","article-title":"Dendritic cell vaccine and cytokine-induced killer cell therapy for the treatment of advanced non-small cell lung cancer","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett."},{"key":"B326","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00262-014-1575-2","article-title":"A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma","volume":"63","author":"Poschke","year":"2014","journal-title":"Cancer Immunol Immunother."},{"key":"B327","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/1078-0432.CCR-13-3017","article-title":"Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma","volume":"20","author":"Chodon","year":"2014","journal-title":"Clin Cancer Res."},{"key":"B328","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature."},{"key":"B329","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/cgt.2010.4","article-title":"Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study","volume":"17","author":"Garc\u00eda-Castro","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"B330","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2015.11.036","article-title":"Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells","volume":"371","author":"Melen","year":"2016","journal-title":"Cancer Lett."},{"key":"B331","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2142\/biophysico.BSJ-2020002","article-title":"Synthetic tissue engineering: programming multicellular self-organization by designing customized cell-cell communication","volume":"17","author":"Toda","year":"2020","journal-title":"Biophys Physicobiology."},{"key":"B332","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13287-017-0598-y","article-title":"Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation","volume":"8","author":"Bora","year":"2017","journal-title":"Stem Cell Res Ther."},{"key":"B333","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5966\/sctm.2014-0161","article-title":"Comparative study of autologous stromal vascular fraction and adipose-derived stem cells for erectile function recovery in a rat model of cavernous nerve injury","volume":"4","author":"You","year":"2015","journal-title":"Stem Cells Transl Med."},{"key":"B334","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.scr.2011.06.003","article-title":"Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application","volume":"7","author":"van Dijk","year":"2011","journal-title":"Stem Cell Res."},{"key":"B335","doi-asserted-by":"publisher","first-page":"789","DOI":"10.5966\/sctm.2013-0032","article-title":"Administration of murine stromal vascular fraction ameliorates chronic experimental autoimmune encephalomyelitis","volume":"2","author":"Semon","year":"2013","journal-title":"Stem Cells Transl Med."},{"key":"B336","doi-asserted-by":"publisher","first-page":"0963689720943581","DOI":"10.1177\/0963689720943581","article-title":"Comparison of bone marrow aspirate concentrate and allogenic human umbilical cord blood derived mesenchymal stem cell implantation on chondral defect of knee: assessment of clinical and magnetic resonance imaging outcomes at 2-year follow-up","volume":"29","author":"Ryu","year":"2020","journal-title":"Cell Transplant."},{"key":"B337","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.arthro.2021.02.022","article-title":"Allogenic human umbilical cord blood-derived mesenchymal stem cells is more effective than bone marrow aspiration concentrate for cartilage regeneration after high tibial osteotomy in medial unicompartmental osteoarthritis of knee","volume":"37","author":"Lee","year":"2021","journal-title":"Arthroscopy."},{"key":"B338","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s11033-020-05428-0","article-title":"Mesenchymal stromal cell and bone marrow concentrate therapies for musculoskeletal indications: a concise review of current literature","volume":"47","author":"Eder","year":"2020","journal-title":"Mol Biol Rep."},{"key":"B339","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.bone.2011.11.002","article-title":"Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells","volume":"50","author":"Zhao","year":"2012","journal-title":"Bone."},{"key":"B340","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.3892\/mmr.2016.5745","article-title":"Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study","volume":"14","author":"Chen","year":"2016","journal-title":"Mol Med Rep."},{"key":"B341","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.arth.2015.06.022","article-title":"Combining concentrated autologous bone marrow stem cells injection with core decompression improves outcome for patients with early-stage osteonecrosis of the femoral head: a comparative study","volume":"30","author":"Tabatabaee","year":"2015","journal-title":"J Arthroplasty."},{"key":"B342","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.bone.2013.08.022","article-title":"The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study","volume":"57","author":"Mao","year":"2013","journal-title":"Bone."},{"key":"B343","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5732\/cjc.009.10772","article-title":"Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK","volume":"29","author":"Wang","year":"2010","journal-title":"Chin J Cancer."},{"key":"B344","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.trecan.2017.12.007","article-title":"Re-emergence of dendritic cell vaccines for cancer treatment","volume":"4","author":"Saxena","year":"2018","journal-title":"Trends in cancer."},{"key":"B345","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fphar.2017.00126","article-title":"Dual functional capability of dendritic cells \u2013 cytokine-induced killer cells in improving side effects of colorectal cancer therapy","author":"Mosi\u0144ska","year":"2017","journal-title":"Front Pharmacol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/CJI.0b013e31816cabbb","article-title":"Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma","volume":"31","author":"Koike","year":"2008","journal-title":"J Immunother."},{"key":"B347","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/icb.2011.11","article-title":"Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine","volume":"90","author":"Lutz-Nicoladoni","year":"2012","journal-title":"Immunol Cell Biol."},{"key":"B348","doi-asserted-by":"publisher","first-page":"7322","DOI":"10.1016\/j.vaccine.2007.08.037","article-title":"The optimal interval for dendritic cell vaccination following adoptive T cell transfer is important for boosting potent anti-tumor immunity","volume":"25","author":"Park","year":"2007","journal-title":"Vaccine."},{"key":"B349","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2249.2010.04226.x","article-title":"Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell\/regulatory T cells in tumour","volume":"162","author":"Song","year":"2010","journal-title":"Clin Exp Immunol."},{"key":"B350","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.clim.2007.12.001","article-title":"Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells","volume":"127","author":"Tamai","year":"2008","journal-title":"Clin Immunol."},{"key":"B351","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.cobme.2017.10.008","article-title":"Engineering multicellular systems: using synthetic biology to control tissue self-organization","volume":"4","author":"Johnson","year":"2017","journal-title":"Curr Opin Biomed Eng."},{"key":"B352","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3389\/fimmu.2020.582744","article-title":"Towards a systems immunology approach to unravel responses to cancer immunotherapy","author":"Bracci","year":"2020","journal-title":"Front Immunol."},{"key":"B353","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/ni.3768","article-title":"Systems immunology: just getting started","volume":"18","author":"Davis","year":"2017","journal-title":"Nat Immunol."},{"key":"B354","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-981-15-4370-8_10","article-title":"Future challenges and perspectives for stem cell therapy of neurodegenerative diseases","volume":"1266","author":"Han","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B355","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J Control Release."},{"key":"B356","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/cncr.30491","article-title":"Adoptive T cell therapy: an overview of obstacles and opportunities","volume":"123","author":"Baruch","year":"2017","journal-title":"Cancer."},{"key":"B357","unstructured":"The Cost of Stem Cell Therapy in 2021.2021"},{"key":"B358","unstructured":"Regenerative Medicine Injection Pricing.2017"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.756029\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T18:17:46Z","timestamp":1673806666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.756029\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":358,"alternative-id":["10.3389\/fmed.2021.756029"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.756029","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"756029"}}